RENOWN NEWSROOM

Two vascular surgeons bring a quarter of a century of experience to patients and community. As part of a continuing focus to bring comprehensive care to patients experiencing cardiac and vascular disease across northern Nevada, Renown Health Department of Surgery and Renown Institute for Heart & Vascular announce that vascular surgeons, John C. Hansen, MD, FACS and Benjamin P. Jaquish, MD, FACS have joined Renown Health.  "Recognizing the significance of preventing, diagnosing and caring for people with heart and vascular disease, which continues to be on the rise and taking far too many lives, is of critical important to us at Renown," says Christos A. Galanopoulos, MD, MBA, MSc, FACS, VP, Chairman Department of Surgery at Renown Health. "Both Drs. Hansen and Jaquish are superb clinicians, skilled investigators, and effective educators. We are fortunate to have them helping to lead the growth of both the department and the Division of Vascular and Endovascular Surgery." Together, the vascular surgeons have more than 26 years of combined experience caring for northern Nevadans. Dr. Hansen has 20 years of experience in northern Nevada. He is a clinical associate professor of surgery at the University of Nevada, Reno School of Medicine (UNR Med) and currently serves as medical director of vascular and endovascular surgery for Renown Regional Medical Center. "Since 2002, Dr. Hansen has led our region with his expertise and knowledge of aortic stents, grafting for abdominal aortic aneurysms and thoracic aneurysms, as well as treating patients with carotid disease," says Jayson Morgan, MD, FACC, Director, Cardiovascular Services. "Dr. Hansen specializes in the comprehensive management of vascular disorders, including open and endovascular surgeries. He is meticulous, thorough, and compassionate in the extraordinary care he provides to patients. We are thrilled that he has joined the Institute for Heart & Vascular Health team at Renown." Dr. Hansen completed his fellowship in Vascular Surgery at the Mayo Clinic in Rochester, MN, and completed his residency in General Surgery at the University of South Carolina, Greenville. He graduated with his Doctor of Medicine from the University of North Carolina School of Medicine, Chapel Hill, and is board certified in both Surgery and Vascular Surgery from the American Board of Surgery and a Fellow of the American College of Surgeons. Dr. Hansen has an interest in complex and acute vascular surgery and is committed to expanding access to qualified vascular care in the region. His mission is to further develop and establish Renown as a premier vascular center in northern Nevada. "Dr. Jaquish has extensive experience in carotid artery disease, carotid endarterectomy, aortic aneurysm and dissection, and peripheral vascular disease," says Sam Obilie-Mante, MBA, MIS, RDCS, RVT, LBBP, VP Administrator, Cardiovascular Services. "Dr. Jaquish is intelligent, professional, conscientious, and always perseveres on behalf of his patients. How proud we are to have him bringing his time and talent to patients across Renown Health." Dr. Jaquish received both his B.S. in Biochemistry (2005), graduating Magna Cum Laude with his Doctor of Medicine (2009) from the University of Nevada, Reno School of Medicine. Dr. Jaquish completed his fellowship in General Surgery at Ascension St. John Hospital and Medical Center in Detroit and a fellowship in Vascular Surgery at Texas A&M at Baylor, Scott & White Hospitals in Temple, TX. He is board certified in both General Surgery and Vascular Surgery. Dr. Jaquish currently serves as Assistant Professor of Clinical Surgery for UNR Med. Dr. Jaquish is bilingual in Spanish, proficient in American Sign Language and serves as an instructor for Advanced Trauma Life Support. Why Vascular and Endovascular Care Matters to You People with complex and serious conditions of the blood vessels and lymph system (vascular diseases) often find the help they need from Renown Health's vascular and endovascular surgical team. Renown's experts provide coordinated and comprehensive treatment to people of all ages. Renown's surgeons use advanced technology to perform vascular and endovascular surgery, including complex stenting procedures, blood clot removal and bypass surgery. Conditions treated include peripheral artery disease, aortic disease, mesenteric disease, nutcracker syndrome and carotid artery disease. "Our expert vascular and endovascular surgeons and staff treat problems that extend from mild to the most critical of emergencies," says Adnan Akbar, MD, Chief Medical Officer for Renown Acute Care. "Specialized physicians including cardiologists, interventional radiologists, heart and vascular surgeons, emergency medicine and trauma surgeons, neurologists, radiologists, physical medicine and rehabilitation specialists, primary care providers, nurses and other clinicians work as a team to determine the best treatment plan for each patient. We encourage all patients to discuss with their primary care providers whether they should undergo formal screening for early vascular disease." "Renown's reputation as the region's vascular and endovascular care leader has been built over many years. We performed the area's first open-heart surgery, angioplasty, stent and valve replacements decades ago. Renown Regional offers incredible advancements like trans-catheter aortic valve replacement (TAVR) and trans-catheter mitral valve repair (TMVr) with MitraClip therapy, lifesaving alternatives to open-heart surgery for patients considered high-risk or inoperable," says Chris Nicholas, FACHE, Chief Executive Officer of Renown Regional Medical Center. "Offering the highest level of comprehensive care for patients experiencing cardiac and vascular disease, Renown developed its first division of cardiothoracic surgery dedicated to heart surgery patients in 2019." The Renown Institute for Heart & Vascular Health program now offers a Diagnostic Electrophysiology Lab; a Chest Pain Center using the D-SPECT® heart camera; multiple Interventional Labs; Heart Failure Program; several Cardiac Catheterization Labs; Interventional Cardiology and Cardiac Surgery when necessary; and the only Pritikin-certified Healthy Heart Program in the West, creating individualized rehabilitation plans tailored to each patient's needs, so they can exercise safely, eat healthy, manage stress and cook nourishing, balanced meals, all while gaining a healthy mindset. In the most recent US News & World Report Best Hospital rankings, Renown Regional Medical Center was named as the number one hospital in Nevada. No other hospitals in the state met their stringent standards for the 2021 rankings. Renown Health is High Performing, its highest rating possible, in eight procedures and conditions including Heart Failure, Colon Cancer Surgery and Chronic Obstructive Pulmonary Disease, Hip Replacement and Knee Replacement. A hospital's score is based on multiple data categories, including patient outcomes, safety and volumes. Hospitals earning a High Performing rating were significantly better than the national average. The 2021-22 Best Hospitals rankings are drawn from a universe of 4,523 facilities, representing nearly all U.S. hospitals providing inpatient care. Hospitals are evaluated across a wide range of conditions and procedures, including 16 medical specialty areas of care. US News & World Report evaluated 58 hospitals in Nevada. Renown Health is Nevada's largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 6,500 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children's hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in a community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org. The University of Nevada, Reno School of Medicine (UNR Med), Nevada's first public medical school, is a community-based, research-intensive medical school with a statewide vision for a healthy Nevada. Since 1969, UNR Med has trained more than 3,900 students, residents and fellows. UNR Med continues to improve the health and well-being of all Nevadans and their communities through excellence in student education, postgraduate training and clinical care, research with local, national and global impact and a culture of diversity and inclusion. For more information, visit med.unr.edu.

Read More About Nationally Recognized Vascular Surgeons Join Renown Health

Innovative anesthesiology practice improves diagnosis, medical management and quality of life for patient. If you are preparing for a surgical procedure, you have probably given a lot of thought to the education, training and experience of the surgeon performing the procedure. But you may not have thought much about the physician anesthesiologist or the importance of his or her medical expertise in your procedure — before, during and after — to keep you safe and comfortable. "Our leadership team has thought a lot about physician anesthesiologists over the past year,” says Sy Johnson, MBA, President and Chief of Staff for Renown Health. “As the region’s only not-for-profit integrated healthcare network and trauma center, we are trusted and chosen by patients as the top provider of inpatient care, including surgeries, for northern Nevada, Lake Tahoe and northeast California. To serve the needs of hundreds of surgeons and thousands of patients with safe, high quality and effective anesthesia coverage, we now employ fifty-six anesthesiologists through our Department of Surgery and have established Renown Medical Group Anesthesiology, a new local practice for northern Nevada.” “Renown Medical Group anesthesiologists provide 24 hour surgical and procedural coverage based on clinical skill sets, surgeon preference and patient preference. Patients who choose Renown for their care can feel certain that they are receiving anesthesia care from a physician anesthesiologist who has attained board certification. Renown Health hospitals are pleased to provide patient care exclusively by physician anesthesiologists,” says Thomas Graf, MD, FAAFP, CEO, Chief Clinical & Quality Officer of Renown Health and Senior Associate Dean for Clinical Affairs at the University of Nevada, Reno School of Medicine. “We are the doctors trained to administer and manage anesthesia given to a patient during a surgical procedure to ensure anesthesia care is as safe and effective as possible,” says Nariman Rahimzadeh, MD. Dr. Rahimzadeh serves as Medical Director and Chief of Staff for Renown South Meadows Medical Center, is a member of the new group and has practiced in Reno for fifteen years. “We also play a key role in taking care of patients who are having minor surgery or who may not require general anesthesia, such as women in labor who need to be awake and alert but require effective pain management.” “Our innovative anesthesiology practice is now staffed by fifty-six anesthesiologists. We are serving patients and surgeons at Renown Health hospitals with one fully integrated model of care to improve diagnosis, medical management and quality of life,” says Christos Galanopoulos, MD, MBA, MSc, FACS; Chair, Department of Surgery and Vice President at Renown Health. “We strive to advance anesthesia through clinical excellence, education, innovation and people. Our nationally recognized medical staff and dedicated support team perform the majority of anesthesia procedures in our market, and evaluate, monitor, and supervise patient care before, during, and after surgery to deliver effective anesthesia and ensure optimal patient safety.” “Physician anesthesiologists have 12 to 14 years of education, including medical school, and 12,000 to 16,000 hours of clinical training,” adds Scott Parkhill, MD, FASA, who serves as a Medical Director and Vice Chief of Staff at Renown Regional Medical Center and is a member of the new group. “Physician anesthesiologists in the United States complete a four-year undergraduate college degree that includes satisfying pre-med requirements. Like other medical doctors, they must follow undergraduate education with four years of medical school. After medical school, a physician specializing in anesthesiology completes a four-year anesthesiology residency program. Following completion of a residency program, residents are eligible to sit for the American Board of Anesthesiology (ABA) exam. We are pleased that all of our Renown Medical Group anesthesiologists are board certified.” Adds Kelsey Larsen, MBA, Chief Operating Officer for Renown Medical Group, “We are thrilled to welcome and employ forty-two physician anesthesiologists who started with us on April 1. An additional nine physicians joined last week and five other physicians have requested to start over the summer for a total of 56 anesthesiologists that have joined Renown Health to provide services to patients.” Patients served include those at Renown Regional Medical Center, the only Level II Trauma Center between Sacramento and Salt Lake City, and named #1 Hospital in the State of Nevada by U.S. News and World Report Best Hospital Rankings for 2021. Physician anesthesiologists will also provide services to patients at Renown South Meadows Medical Center, named #1 Best Hospital for 2020 by U.S. News & World Report; and to patients at Renown Rehabilitation Hospital, northern Nevada’s only Commission on Accreditation of Rehabilitation Facilities (CARF) accredited hospital, specializing in the treatment of patients with brain injury, spinal cord injury and stroke. Renown Health is integrated with the University of Nevada, Reno School of Medicine, Nevada’s first medical school, which serves to enhance the health of the community through increased access to care, innovative health care delivery, expansion of clinical research and training for the next generation of physicians and health care professionals. 51 ANESTHESIOLOGISTS WHO JOINED RENOWN IN APRIL 2022: Samuel Beck, MD Heber Becker, MD  Peter Billharz, MD  Kara Bjur, MD  Brian Brewer, MD Brian Buehler, MD Carrie Buehler, MD Catherine Burton, MD Joshua Cartinella, MD  Nicholas Cirac, MD  Gordon Curry, MD  Scott Dougan, MD  JoAnn Ellero, MD  Daryl Fenio, MD  Dirk Fletcher, MD  Tobey Gansert, MD  Benjamin Garol, MD  Jeffery Grudzinski, MD  Keith Hanson, MD  Min Hein, MD  Mark Janes, MD  Scott Jeannes, MD  Kevin Lasko, MD  Sarah Lim, MD  Jay Markin, MD John Marshall, MD  Eric Moody, MD  John Mortensen, MD  Jobin Nash, MD Mel Nutter, DO      Scott Parkhill, MD   Nariman Rahimzadeh, MD   Suresh Raman, MD   Shaina Richardson, MD   Alan Sarabia, MD   Heidi Sarabia, MD   Mitch Seman, MD   Daniel Sorensen, MD   Ryan Stites, MD   Aaron Wallace, MD   Duncan Browne, MD   Tyler Hartley, MD   Jie Lan, MD  Pamela Russell, MD  Scott Reineck, MD   Brian Landreth, DO      Kara Sievert, MD   Chiaki Nakanishi, MD  Philip Phu, MD  Matthew Sabatini, MD   Robert Kyper, MD  About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org

Read More About 56 Anesthesiologists Join Renown Health to Provide High Quality Services to Area Patients and Surgeons

Always listening to the voice of the patient, Renown Health is pleased to welcome any two patient supporters to visit their loved ones during their Renown medical visit, surgery, birthing or hospital stay. Renown continues to have extra safety measures in place to protect the health of patients, visitors and healthcare employees, and as the situation changes with COVID-19, these guidelines are subject to change. Under this updated visitor policy, patients no longer need to identify their supporters ahead of their arrival. Patients may receive more than two visitors per day; however, to help ensure adequate physical distancing, only two guests are asked to visit at a time. All people entering Renown sites must continue bringing and wearing a face mask for their entire visit, including inside patient rooms. Renown’s visitor policy updates were inspired by family members, who requested that the policy be expanded to encourage two family members per day to be able to visit a loved one who was hospitalized at Renown. The request was approved by Dr. Debra Adornetto-Garcia, Chief Nursing Officer and Dr. Paul Sierzenski, Chief Medical Officer, both of Acute Services. With a high percentage of Renown hospital staff now vaccinated against COVID-19, declining hospitalizations of patients with COVID-19, and understanding that the best communication is in-person, as of April 28, 2021, Renown hospitals and medical practices now allow two visitors, instead of one, for all patients and have put extra safety measures in place to protect patients, visitors and healthcare employees. “We are pleased to expand our visitor policy and welcome two healthy adult patient supporters to accompany every patient to their Renown medical visit or hospital stay,” said Tony Slonim, MD, DrPH, President & CEO of Renown. “We are always looking to our patients’ lived experiences to help us address the health needs of our community. Just a few months ago, we were reminded by Darlene Randolph that the best care is ‘person-centered care’, which inspired us to be one of the first healthcare organizations in the nation to expand our visitor policy to all patients, including those with COVID-19. Today, we thank our patients’ family members for voicing the importance of a larger, connected support system to help foster the best healing environment for all patients.” “At Renown, the definition of ‘family’ is defined by the patient,” said Debra Adornetto-Garcia, DNP, RN, NEA-BC, AOCN, Chief Nursing Officer, Acute Services. “Our patients may have anyone they choose as their patient supporters, and these individuals serve as an invaluable extension of our care teams. Patient supporters are asked to partner with the patient’s healthcare team to assist in communicating to other family members and friends, participating in training and education activities and assisting the patient with complying with care and medication instructions.” “Visiting the hospital can be an anxious experience,” said Paul Sierzenski, MD, MSHQS, CPE, FACEP, Chief Medical Officer, Acute Services. “It’s incredible how the company of loved ones can reduce anxiety and promote healing. What we can do together with families to support patient care and excellent outcomes is greater than what any of us can do alone. We are glad to welcome patient supporters to our hospitals to help our patients feel more at ease, so they can focus on their recovery, health and healing.” Two patient supporters per patient are now able to access Renown campuses as noted: Renown Regional Medical Center and Renown South Meadows Medical Center: 8 a.m. to 8 p.m. For Intensive Care Units (ICU): 9 a.m. to 8 p.m. Visitors must be at least 12 years of age or older. Renown Children’s Hospital: Open access. For the Pediatric unit and Pediatric Intensive Care Unit (PICU): Visitors must be at least 12 years of age or older. For the Neonatal Intensive Care Unit (NICU): Visitors must be at least 18 years of age or older. Renown Rehabilitation Hospital: 8 a.m. to 5 p.m. One designated patient supporter is allowed to visit the patient inside their room throughout the duration of their stay. Other loved ones may visit from an exterior window, outside the patient's room. Our care team is also pleased to facilitate bedside virtual visits. In addition to in-person visits, there are many ways to brighten the day of a patient at Renown Hospitals. You can send a personalized message that will be hand-delivered to your loved one, call 775-982-4100 to speak with a patient, or our care team is pleased to facilitate virtual visits via computer or tablet from the bedside. Renown Health reserves the right to limit visitors in the best interests of patients, families, visitors or staff.   About Renown Health Renown Health is Nevada’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 6,500 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in a community-based genetic population health study, the Healthy Nevada Project®.

Read More About Renown Health Further Expands Visitor Policy to Two Loved Ones

Renown hospitals are among the first in the country to lift visitor restrictions for patients with COVID-19 and encourage family to be at the patient's bedside. True treasure hunters, Dr. Dave and Darlene found joy in exploring antique shops and garage sales to find damaged or discarded vintage pieces. After hauling the item home, Dave would spend many hours scraping it clean, sanding and refinishing it, until it gleamed and became a polished, functional and beautiful piece of furniture. Every piece in their home rekindles a memory and has a story to tell.  On Thanksgiving, when Dave was too ill to gather around their antique dining room table, Darlene called the ambulance. Dave had been ill with COVID-19 for two weeks and had not been improving. When the EMTs reached her home and asked Darlene what underlying conditions he had, she said, “all of them.” David was seriously ill. Hospitalized for COVID-19, their communications options were limited. The only way Darlene could communicate with Dave was on a video call, or by telephone. Dave spent 17 days hospitalized at Renown Regional Medical Center in Reno. Darlene spent 17 days waiting by the phone for more information. Darlene said he had “up days and down days,” but thought he might be home, sitting at their antique dinner table for Christmas.  David Ivan Randolph was born in Boston, MA on August 29, 1936. He grew up in Roxbury and graduated from the prestigious Boston Latin Boys School. He obtained a Bachelor of Arts in General Psychology, an MA in Experimental Psychology from Northeastern University and a PhD in Sensory Psychology & Physiology from the University of Massachusetts, Amherst. While in university he joined ROTC and upon graduation was commissioned as a First Lieutenant in the Army Medical Specialist Corp. After basic training at the Fort Sam Houston Medical Training School he was assigned as a Captain, Research Psychologist to the US Army at the Pioneering Research Division in Natick, MA. Over the next 30 years, he conducted vision research at Fort Knox, KY; Philadelphia, PA and then with the newly constructed Letterman Army Institute of Research (LAIR), Division of Ocular Hazards at the Presidio of San Francisco, CA. David continued his vision research at LAIR until his retirement in 1992 when the Presidio was decommissioned. Dr. Randolph’s research findings in flash blindness and night vision made him a sought-after presenter at research conferences in the US and abroad. In a PBS documentary he was interviewed as part of the team that developed goggles that protect soldiers from laser eye damage. Dr. David Randolph lost his battle with COVID-19 on December 13, 2020, and died as he slept in a hospital bed. When Darlene wrote his obituary for the newspaper, she gave thanks to the “tremendous nurses and doctors at Renown Regional Medical Center, for providing his care during a time when family could not be with him.” Darlene wished she could have been there. Over their 45-year marriage, she had always been there. Darlene said, “I had always been at his bedside, as his advocate, to help communicate and straighten things out.” As a registered dietician, she worked in hospitals and knew the protocol. She knew, like hospitals across the globe, Renown had restricted family members from visiting in order to stop the spread of the virus- to other patients, staff and their family members. Still, she wished she could have spent more time with him. On Christmas Eve, she sat down and wrote to Dr. Anthony Slonim, president and chief executive officer of Renown Health in Reno, NV. “Dear Doctor Slonim, as the wife of a COVID patient who recently passed away in your hospital, I want to express my thanks to you and your staff for the care he was given in the last days of his life. I am aware that the nurses and staff are working under dangerous conditions and risking their health and lives by caring for multiple COVID patients. The staff was gracious, concerned and did everything they could for my husband and myself.” She continued, “I know procedures are changing every hour to try to stay ahead of this dangerous virus and I am sharing my experiences hoping they will be helpful when establishing policies that impact families.” Darlene explained that despite receiving assurances that Dave’s nurse or even a doctor would call daily, sometimes they would forget. She explained in her letter, “how important it was, in these times when family cannot visit, and has only infrequent communication and is anxiously waiting at home for word of their loved one, how much it means to get a call from someone caring for him at the hospital.” Darlene asked, “If there is any way you can help to assure that nurses have time to make calls or assist patients to make calls, because it is an important part of patient care.”  After receiving her letter, Dr. Slonim called Mrs. David Randolph, to thank her, to offer his sympathies and to ask if Renown could help in any way. Darlene asked if he might reconsider allowing families to visit hospital patients being treated for COVID-19. Dr. Slonim, who had also lost his father to COVID-19 back in April at a hospital in New Jersey, asked his leadership team to review Mrs. Randolph’s request and make a recommendation. The hospital leadership team made a recommendation to Dr. Slonim that was immediately approved. As the COVID-19 situation has evolved, the policy has as well. With a high percentage of Renown hospital staff now vaccinated against COVID-19, declining hospitalizations of patients with COVID-19, and understanding that the best communications are in-person, as of Wednesday morning, Jan. 27, 2021, Renown hospitals and medical practices now encourage limited visitors for all patients, including those diagnosed with COVID-19. Renown continues to have extra safety measures in place to protect the health of patients, visitors and healthcare employees, and as the situation changes with COVID-19, these guidelines are subject to change. “As of today, one healthy adult Patient Supporter may now accompany every patient to their Renown medical visit or hospital stay,” Tony Slonim, MD, DrPH, President & CEO of Renown said, “We live by our values of caring, integrity, collaboration and excellence. We thank Darlene for reminding us that the best care is ‘person-centered care,’ an approach that embraces the perspective of the patient and their loved ones, while promoting a healthy, encouraging environment for caregivers and addressing the health needs of our community.”  “At Renown, the definition of "family" is defined by the patient,” says Debra Adornetto-Garcia, DNP, RN, NEA-BC, AOCN, Chief Nursing Officer, Acute Services. “Our patients may designate anyone they choose as their Patient Supporter. The Patient Supporter is incredibly important and part of the care team. The Patient Supporter will be asked to partner with the patient’s health care team to assist in communicating to other family members and friends, participating in training and education activities and assisting the patient with complying with care and medication instructions.” “When it comes to healing and recovery, everyone's role is important,” emphasizes Paul Sierzenski, MD, MSHQS, CPE, FACEP, Chief Medical Officer, Acute Services. “What we can do together to support patient care and excellent outcomes is greater than what any of us can do alone. This belief shapes our work, our services and the care we provide to patients, their families and friends at Renown.” “I am pleased that Renown Health has modified the visitation policies so that each patient can have a designated visitor. As a former ICU patient and current ICU physician, I know the importance of having a loved one’s support in the hospital and I am thrilled we are able to accommodate this incredibly important aspect of patient care,” says Jacob B Keeperman, MD, FACEP, FAAEM, FAEMS, FCCM, Medical Director, Renown Regional Transfer and Operations Center, Intensivist. When Darlene was told that her letter inspired this shift in visitor policies for patients with COVID-19, she was very pleased and said, “I have always tried to think of ways I could help other families, especially those senior couples where one has been hospitalized and the other is home. My wish is to help others.” In alignment with the national guidelines, as of 1/27/2021, one Patient Supporter per patient will be able to access Renown Regional Medical Center and Renown South Meadows Medical Center as noted: Visiting hours for all patients, including those diagnosed with COVID-19 will be extended to 8 am - 8 pm (previously 3-8 pm). All patients are now encouraged to designate up to two Patient Supports. Due to space constraints, we ask that Patient Supports visit one at a time. Patients will provide Names of up to two Patient Supporters during patient admission/registration. Patient Supporter names will be entered into the patient's electronic medical record for patient privacy and security. Renown Children’s Hospital: Open access. (Two parents and/or guardians may be designated as Patient Supporters, however, due to current space constraints, we ask that you visit one at a time). For more detailed information on the Patient Supporter program visit https://www.renown.org/interact/.   About Renown Health Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Heath and Neurosciences. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project® . For more information, visit renown.org.

Read More About Reno Widow Inspires New Patient Supporter Visitor Policy

Healthy Nevada Project’s community-based approach reveals up to 90% of CDC Tier 1 genetic condition risks missed using clinical care guidelines. In a new study published today in the journal Nature Medicine, researchers behind the Healthy Nevada Project® suggest that community-based genetic screening has the potential to efficiently identify individuals who may be at increased risk for three common inherited genetic conditions known to cause several forms of cancer and increased risk for heart disease or stroke. In 2018, the Healthy Nevada Project® (the largest, community-based population health study combining genetic, clinical, environmental and social data) started notifying consenting study participants who have certain genetic variants which predispose them to the Centers for Disease Control and Prevention (CDC) Tier 1 genetic conditions. The study focused on identifying carriers of these conditions, which include Hereditary Breast and Ovarian Cancer, Lynch Syndrome, and Familial Hypercholesterolemia, because they are the most common conditions and early detection and treatment could significantly lower morbidity and mortality. Initial results from almost 27,000 study participants showed that 90% of carriers of the CDC Tier 1 genetic conditions were not previously identified in a clinical setting. The authors conclude that population genetic screening would identify at-risk carriers not identified during routine care. “Our first goal was to deliver actionable health data back to the participants of the study and understand whether or not broad population screening of CDC Tier 1 genomic conditions was a practical tool to identify at-risk individuals,” explained Joseph Grzymski, Ph.D., the principal investigator of the Healthy Nevada Project®, a research professor at the Desert Research Institute (DRI), chief scientific officer for Renown Health and lead author of the study. “Now, two years into doing that, it is clear that the clinical guidelines for detecting risk in individuals are too narrow and miss too many at risk individuals.” Within the group of 26,906 Healthy Nevada Project® participants that Grzymski’s research team studied, 358 (1.33%) were carriers for CDC Tier 1 conditions. However, only 25% of those individuals met clinical guidelines for genetic screening. Additionally, more than 20% of the carriers already had a diagnosis of disease relevant to their underlying genetic condition. “We’re at a point now where it’s possible to do clinical-grade genetic screening at population-scale,” added James Lu, M.D. Ph.D., co-founder and chief scientific officer of Helix and senior co-author of the study. “What this study demonstrates is the potential impact of doing so. By making genetic screening available more broadly, we can help the millions of Americans who are unaware that they are living at increased risk for highly actionable, genetic conditions take action.” Most notably, the study found that of the 273 participants who were carriers of the CDC Tier 1 genetic conditions and had clinical record information, only 22 individuals showed any previous suspicion of their underlying genetic conditions. “For the first time, we are providing information at the individual level so study participants can make lifesaving changes to reduce their risk based on their genetics,” said Anthony Slonim, M.D., Dr.PH., FACHE, president and CEO of Renown Health and co-director of the Project® study. “We’re conducting research on the community level to develop leading-edge research on health determinants for entire neighborhoods, states and eventually, the country. Returning these results allows us to understand the prevalence of genetically programmed diseases and illnesses that we have here in Nevada and ensure we are providing the best prevention and care plans. For the individual, the return of results can be life changing.” According to the CDC, early detection and intervention of the Tier 1 genetic conditions could have a meaningful potential for clinical action ability and a positive impact on public health. The Healthy Nevada Project®, which launched in 2016, offers free genetic testing to every Nevadan, aged 18 and older, interested in learning more about their health and genetic profile. With more than 50,000 study participants enrolled in four years, the Healthy Nevada Project® has become the fastest-enrolling genetic study in the world. For more about the Healthy Nevada Project® please visit healthynv.org     Renown Institute for Health Innovation is a collaboration between Renown Health – a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute – a recognized world leader in investigating the effects of natural and human induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at Healthynv.org. Helix is the leading population genomics company operating at the intersection of clinical care, research, and genomics. Its end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. Powered by one of the world's largest CLIA / CAP next-generation sequencing labs and its proprietary Exome+Ⓡ assay, Helix supports all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research. In response to the COVID-19 public health crisis, Helix has launched a sensitive and scalable end-to-end COVID-19 test system to meet the needs of health systems, employers, governments, and other organizations across the country. Learn more at www.helix.com.

Read More About Population Genetic Screening Show to Efficiently Identify Increased Risk for Inherited Disease

Presented by the Desert Research Institute and Renown Health, DANA will help people learn more about the Healthy Nevada Project® and their own unique, genetic health traits What is the Healthy Nevada Project®? What are the benefits of joining this research study? How can I find out if I carry genes for health risks like heart disease, hereditary breast and ovarian cancer syndrome and Lynch syndrome? What if a holographic avatar, powered by artificial intelligence (AI), could answer all these questions and more? DANA has all the answers, she is a virtual assistant with “DNA” in her name, presented by the Renown Institute for Health Innovation (Renown IHI), a collaboration between Renown Health and the Desert Research Institute (DRI). This life-sized, holographic avatar will greet individuals outside Renown Regional Medical Center’s Sierra Café, and talk to them about the Healthy Nevada Project, the world’s largest community-based genetic population health study. Members of the media are invited to meet DANA this morning from 10 a.m. – noon. Please reply to this email or call (775) 691-7308 to coordinate a meet and greet. “Unfortunately, Nevada ranks among the lowest in the nation for health outcomes—and we are working to change that,” said Anthony Slonim, M.D., D.Ph., president and CEO of Renown Health and president of Renown Institute for Health Innovation. “Through the Healthy Nevada Project® , our goal is to offer genetic testing to every Nevadan interested in learning more about their health and genetic profile. Thanks to this advanced technology, DANA will offer people a personalized explanation of the Project, and help them take the next step to better understand their health, and their health risks, so they can modify their behavior and ultimately, live a healthier, happier life.” With more than 51,000 study participants enrolled to date, the Healthy Nevada Project® is considered the fastest-enrolling genetic study in the country. The Project is also the first of its kind to return clinical results to study volunteers, which means participants can learn their genetic risks tied to heart disease and certain cancers, as well as lifestyle changes that could potentially help reduce their risk and prevent disease. Furthermore, participants can choose to share their information with their medical provider to improve and enhance their medical care. “We are always happy to engage with our study participants and look forward to having them meet and engage with DANA,” said Joseph Grzymski, Ph.D., research professor at DRI, principal investigator of the Healthy Nevada Project® and chief scientific officer for Renown Health. “At a time of physical distancing and limiting human contact where possible, using tools like an avatar and AI are important for communicating, whether it be for genetics, vaccinations or other important health information.” Visitors can interact with DANA through a touch screen (cleaned and sanitized after every encounter) to learn more about the study, enter their contact information and schedule an appointment to join the free genetics study or receive more information about their test results. Kiosk visitors are asked to maintain physical distance guidelines and use the hand sanitizer and Sani Wipes available next to the kiosk.     Renown Institute for Health Innovation is a collaboration between Renown Health - a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute - a recognized world leader in investigating the effects of natural and human-induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at healthynv.org.

Read More About Introducing Dana Renown Institute for Health Innovations New Life Sized Holographic Kiosk

Gilead Sciences, Inc. (Nasdaq: GILD) and the Renown Institute for Health Innovation (IHI) today announced a strategic collaboration to collect and analyze genetic and electronic health data that can enhance the understanding of nonalcoholic steatohepatitis (NASH) and potentially inform development of treatment options for the disease. Under the terms of the collaboration and license agreement, Gilead will provide funding to Renown IHI to sequence and analyze the DNA of 15,000 individuals living with NASH or nonalcoholic fatty liver disease (NAFLD) as well as a control cohort of 40,000 individuals in Nevada. “Combining the sequencing of protein coding DNA, with extensive electronic health record data will enable a deep analysis of the roles of genetics and environment in NASH incidence and progression,” said John McHutchison, AO, MD, Chief Scientific Officer and Head of Research and Development, Gilead Sciences. “The analysis of these large datasets in collaboration with Renown IHI could help identify genetic variants that impact the risk of developing NASH and thereby advance the discovery and development of new treatments for this disease.” Renown Health is Nevada’s most comprehensive and integrated healthcare network and maintains electronic health records for 1.02 million registered patients. In 2016, Renown Health and the Desert Research Institute established the Healthy Nevada Project (HNP), the nation’s first community-based population health study. In 2017 HNP began a partnership with Helix to leverage its population health services, Exome+™ sequencing, and consumer engagement tools. The HNP is now an ongoing collaboration between Renown IHI, the Desert Research Institute, a global leader in environmental data and applied research, and Helix, a personal genomics company. HNP combines genetic, environmental, social and clinical data to address individual and community health needs with the goal of improving health across the state and the nation. The HNP currently has 40,000 participants. “Combining genetic sequencing with large sets of data can play a critical role in understanding and identifying serious health risks, including diseases like NASH. We are excited to collaborate with Gilead to better understand the condition and its complexities,” said Anthony Slonim, MD., DrPH. “Any genetic variants identified in participants through the collaboration may be shared with the participants for patient care purposes.”     About NASH Nonalcoholic steatohepatitis (NASH) is a chronic form of liver disease characterized by excess fat in the liver, inflammation, and liver cell damage. Inflammation and liver cell damage can cause scarring of the liver, or fibrosis, and ultimately lead to cirrhosis or liver cancer. NASH is more common in people with certain conditions, including obesity and type 2 diabetes. There are currently limited approved treatments for patients living with NASH.   About Gilead Sciences Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com.   About Renown Health Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown Health’s commitment has extended beyond traditional health care to include community health and well-being. Renown Health works to improve health care through science, research and genetics; forge community partnerships that improve lives and develop innovative models that are improving health care in Nevada. For more information, visit renown.org.    About Helix Helix’s mission is to empower every person to improve their life through DNA. Helix is accelerating the integration of genomic data into clinical care and broadening the impact of large-scale population health programs by providing comprehensive expertise in DNA sequencing, bioinformatics, and individual engagement. Powered by their proprietary Exome+™ assay—a panel-grade exome enhanced by more than 300,000 informative non-coding regions—Helix offers health systems a scalable solution which enables the discovery of medically relevant, potentially life-saving, genetic information. Additionally, Helix offers a suite of DNA-powered products for continued individual engagement and discovery. Helix is headquartered in the San Francisco Bay Area and has one of the world’s largest CLIA-certified, CAP-accredited Next Generation Sequencing labs, located in San Diego, California. Learn more at www.helix.com. Helix, the Helix logo, and Exome+ are trademarks of Helix Opco, LLC.   Gilead Forward-Looking Statement This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks, uncertainties and other factors, including the risk that the parties may not realize the potential benefits of this collaboration, and Gilead may fail to discover, develop and commercialize any product candidates for the treatment of NASH. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These risks, uncertainties and other factors could cause actual results to differ materially from those referred to in the forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. These and other risks are described in detail in Gilead’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, as filed with the U.S. Securities and Exchange Commission. All forward-looking statements are based on information currently available to Gilead, and Gilead assumes no obligation to update any such forward-looking statements. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.   Additional Media Contact: Sung Lee, Investors                                                                                                                                                        650-524-7792 Arran Attridge, Media                                                                                                                                                        650-425-8975

Read More About Gilead Sciences and Renown Institute for Health Innovation Announce Strategic Collaboration to Advance Understanding of Nonalcoholic Steatohepatitis (NASH)